Orders from 465 AED Free delivery from 965 AED Ready for pickup dead drop: collect in 5 min

Substances · Phenethylamine derivatives

4-FMA

C10H14FN CAS 52063-62-4 Analytical reference material — not for human consumption
Preferred name
4-FMA
IUPAC name
1-(4-fluorophenyl)-N-methylpropan-2-amine
Parent CAS number (reference)
52063-62-4
Molecular formula
C10H14FN
Molecular weight
167.22 g/mol
InChIKey
YCWZPIHKUYZTFM-UHFFFAOYSA-N
PubChem
CID 11745017
Source
PubChem
Verified synonyms & catalog abbreviations
4-Fluoromethamphetamine 4FMA 4 FMA

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

4-FMA

Entactogen / stimulant (serotonergic releaser) Ring-fluorinated methamphetamine (para-fluoro)
Verified PubChem & CAS Identity C10H14FN · CAS 52063-62-4 · CID 11745017
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 167.22 g/mol
Peer-Reviewed & Agency Citations 3 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

4-FMA is the para-fluoro analogue of methamphetamine. Para-fluorination, as with 4-FA, shifts the releaser profile toward serotonin as well as dopamine and norepinephrine, so the subjective feel is more entactogenic than 2-FMA. The same para-fluoro pattern is the one associated with cardiotoxicity and hemorrhagic stroke in the 4-FA literature. 4-FMA should be treated as sharing that concern, not as a harmless longer 2-FMA.

Biotransformation & Active Metabolites

Likely N-demethylates toward 4-FA. That does not make the oral charts identical: PsychonautWiki places 4-FMA common at 50–100 mg and 4-FA common at 100–130 mg, with different durations.

Temporal Pharmacokinetics

Entactogenic stimulant: warmth and sociability laid over a long catecholamine push, with a harder cardiovascular reputation than 2-FMA.

  1. Onset 20–40 minutes
  2. Peak Window 2–5 hours
  3. Total Window 4–8 hours
  4. Residual / Half-Life After-effects 3–12 hours of insomnia, low mood, and residual stimulation. Human half-life is not established.

Threshold 10 mg, light 25–50 mg, common 50–100 mg, strong 100–125 mg, heavy above 125 mg. Strong and heavy are only 25 mg apart. A severe headache on 4-fluoroamphetamine compounds is a reason to seek emergency care, by analogy with the 4-FA stroke reports, not a reason to take a painkiller and continue.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
10 mg
Cognitive & Sensory

Light mood lift and wakefulness.

Somatic & Autonomic

Small pulse increase.

Light
25–50 mg
Cognitive & Sensory

Mild sociability and stimulation without a full entactogenic wave.

Somatic & Autonomic

Appetite loss, dry mouth, and jaw awareness.

Common Reference
50–100 mg
Cognitive & Sensory

Warm mood elevation, talkativeness, and music enhancement alongside clear stimulation.

Somatic & Autonomic

Tachycardia, sweating, bruxism, dilated pupils, and vasoconstriction.

Strong
100–125 mg
Cognitive & Sensory

Intense entactogenic stimulation, scattered thought, and irritability as the serotonin tone peaks.

Somatic & Autonomic

Marked hypertension, hyperthermia risk, and a headache that must not be ignored.

Heavy / Toxic Zone
125 mg+
Cognitive & Sensory

Agitation, confusion, and a toxic stimulant state rather than 'more empathy'.

Somatic & Autonomic

Chest pain, severe headache, possible cerebrovascular symptoms, seizures with tramadol, and serotonin toxicity if another releaser is present.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.

Other serotonin releasers (MDMA, 4-FA, 5-MAPB, 6-APB, MDA)

Stacked serotonin release is a serotonin-syndrome pattern, with hyperthermia and seizures.

25x-NBOMe and 25x-NBOH

Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.

Elevated Hazard — Avoid

Other stimulants, cocaine, and high-dose caffeine

Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.

Alcohol, opioids, and benzodiazepines

The stimulant hides sedation. When it drops, the depressant remains.

Tramadol

Seizure threshold plus serotonin reuptake inhibition on a serotonergic releaser.

Caution / Receptor Attenuation

Cannabis

Often increases heart rate and paranoid thought on the offset.

SSRIs and SNRIs

Blunt the serotonergic portion of entactogen-type members while the cardiovascular load stays. They are not protection against serotonin toxicity.

Structural Isomer & Sibling Comparison

4-FMA shares the formula C10H14FN and the mass 167.22 g/mol with 2-FMA but not the dose or the feel. 2-FMA common is 15–30 mg of a flat functional stimulant. 4-FMA common is 50–100 mg and warmer. 4-FA is the primary amine, common 100–130 mg, with a published stroke signal and an even tighter strong band (130–150 mg). Treating them as one 'fluoro' powder is how those numbers get swapped.

Physicochemical Stability & Storage

Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.

Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.

Cross-Tolerance & Dependence Profile

Stimulant tolerance and serotonergic depletion both apply. Acute tolerance halves over several days to two weeks. Cross-tolerance with amphetamines and with MDMA-like releasers. Repeating entactogenic doses in the same week mainly increases cardiovascular load and worsens the crash.

Comprehensive Analytical & Toxicological Monograph

4-FMA (1-(4-fluorophenyl)-N-methylpropan-2-amine; CAS 52063-62-4, PubChem CID 11745017) is the para-fluorinated methamphetamine supplied as pure powder or crystals (C10H14FN, 167.22 g/mol). Para-fluorination adds serotonin release on top of dopamine and norepinephrine, so it feels warmer than 2-FMA and shares the cardiovascular concern attached to 4-FA. PsychonautWiki oral bands are threshold 10 mg, light 25–50 mg, common 50–100 mg, strong 100–125 mg, and heavy above 125 mg, over 4–8 hours. Strong and heavy are close. A sudden severe headache is an emergency signal in this fluoro series. Do not combine with MAOIs, MDMA or other releasers, tramadol, or 25x-NBOMe. It is not 2-FMA despite the identical molecular formula.

Chemical Architecture & Structural Profile

4-FMA (1-(4-fluorophenyl)-N-methylpropan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C10H14FN and a molar mass of 167.22 g/mol. The parent molecule is indexed under CAS registry number 52063-62-4 and in the NCBI PubChem database as CID 11745017 (Standard InChIKey: YCWZPIHKUYZTFM-UHFFFAOYSA-N). This molecule shares its empirical formula (C10H14FN) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (52063-62-4), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 4-FMA is indexed within the Substituted amphetamines structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations

Unsafe combinations (elevated hazard)

Uncertain combinations (caution advised)